Form D · Biotechnology
Rafael Holdings, Inc.
Newark, NJ · CIK 0001713863
Offering snapshot reported Aug 26, 2021 · SEC filing
- Reported sold
- $104M Offering amount: $104M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 24, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 26, 2021 | Initial | $104,169,835 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $5.95M
- Finders' fees
- $0
- Form D file number
- 021-411338
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| SVB Leerink LLC | 39011 | |
| Raymond James & Associates, Inc. | 705 |
Source: Form D, filed Aug 26, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Menachem Ash | Executive |
| Stephen Greenberg | Director |
| Howard S. Jonas | Director |
| Rachel Jonas | Director |
| Shannon Thyme Klinger | Director |
| Ameet Mallik | Director, Executive |
| Mark Mc Camish | Director |
| Boris C. Pasche | Director |
| David A. Polinsky | Executive |
| Michael J. Weiss | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
520 Broad Street
Newark, NJ, 07120
Newark, NJ, 07120